RPS16: A Non-Code RNA Molecule with Potential as A Drug Target Or Biomarker

Target Name: RPS16

NCBI ID: G6217

RPS16

RPS16: A Non-Code RNA Molecule with Potential as A Drug Target Or Biomarker

RNA-protein interactions are a crucial aspect of gene regulation and are involved in various cellular processes. One such interaction is the RNA-protein interaction known as RPS16 (RNA-Protein-S16), which is a protein that plays a significant role in regulating gene expression and has been identified as a potential drug target or biomarker.

RPS16 is a non-coding RNA molecule that is composed of 16 different RNA subunits. It has been shown to interact with a wide range of protein molecules, including transcription factors, shearing enzymes, RNA-binding proteins, etc., and has been shown to play a role in various cellular processes such as cell growth, apoptosis, and translation.

One of the unique features of RPS16 is its ability to interact with multiple proteins at the same time, which allows it to regulate gene expression at multiple levels. This is accomplished through a process called post-transcriptional modification (PTM), which involves the addition or removal of specific chemical groups to or from a protein after its synthesis.

PTMs play a crucial role in the regulation of gene expression and are involved in the development and progression of various diseases, including cancer. The ability of RPS16 to interact with multiple PTMs has led to its potential as a drug target or biomarker.

In addition to its role in gene regulation, RPS16 has also been shown to play a role in the regulation of protein stability and has been shown to interact with protein-protein interactions (PPIs) that are involved in protein stability and translation efficiency.

RPS16 has also been shown to be involved in the regulation of cellular processes such as cell adhesion, migration and invasion. It has been shown to play a role in the regulation of cell-cell adhesion by interacting with E-cadherin, a protein that is involved in cell-cell adhesion.

In addition, RPS16 has also been shown to play a role in the regulation of cell migration and invasion. It has been shown to interact with the protein, Par-Q, which is involved in the regulation of cell adhesion and migration.

Furthermore, RPS16 has also been shown to play a role in the regulation of protein translation efficiency. It has been shown to interact with the protein, translation factor IFP-1, which is involved in the regulation of protein translation efficiency.

In conclusion, RPS16 is a non-coding RNA molecule that has been shown to play a role in various cellular processes and has been identified as a potential drug target or biomarker. Its ability to interact with multiple proteins and its role in the regulation of gene expression, protein stability, and cellular processes such as cell adhesion, migration and invasion make it an attractive target for further research. Further studies are needed to understand the full function and potential of RPS16 as a drug target or biomarker.

Protein Name: Ribosomal Protein S16

Functions: Component of the small ribosomal subunit (PubMed:23636399). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RPS16 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS16 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets